Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma

被引:2
作者
Smalley, Keiran S. M. [1 ,2 ]
Fedorenko, Inna V. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33607 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33607 USA
基金
美国国家卫生研究院;
关键词
BRAF; ephrin; melanoma; metastasis; resistance;
D O I
10.1080/23723556.2015.1008291
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent analyses by our group and others showed that the majority of melanoma patients who fail BRAF inhibitor therapy do so at new disease sites. Using phosphoproteomics we showed that BRAF inhibition mediates a switch to an aggressive/metastatic melanoma phenotype that is driven by ligand-independent erythropoietin-producing hepatocellular receptor A2 (EphA2) signaling.
引用
收藏
页数:3
相关论文
共 10 条
[1]   The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas [J].
Binda, Elena ;
Visioli, Alberto ;
Giani, Fabrizio ;
Lamorte, Giuseppe ;
Copetti, Massimiliano ;
Pitter, Ken L. ;
Huse, Jason T. ;
Cajola, Laura ;
Zanetti, Nadia ;
DiMeco, Francesco ;
De Filippis, Lidia ;
Mangiola, Annunziato ;
Maira, Giulio ;
Anile, Carmelo ;
De Bonis, Pasquale ;
Reynolds, Brent A. ;
Pasquale, Elena B. ;
Vescovi, Angelo L. .
CANCER CELL, 2012, 22 (06) :765-780
[2]   Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma [J].
Carlino, Matteo S. ;
Gowrishankar, Kavitha ;
Saunders, Catherine A. B. ;
Pupo, Gulietta M. ;
Snoyman, Stephanie ;
Zhang, Xu Dong ;
Saw, Robyn ;
Becker, Therese M. ;
Kefford, Richard F. ;
Long, Georgina V. ;
Rizos, Helen .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (07) :1332-1342
[3]   Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance [J].
Das Thakur, Meghna ;
Salangsang, Fernando ;
Landman, Allison S. ;
Sellers, William R. ;
Pryer, Nancy K. ;
Levesque, Mitchell P. ;
Dummer, Reinhard ;
McMahon, Martin ;
Stuart, Darrin D. .
NATURE, 2013, 494 (7436) :251-255
[4]   Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma [J].
Girotti, Maria R. ;
Pedersen, Malin ;
Sanchez-Laorden, Berta ;
Viros, Amaya ;
Turajlic, Samra ;
Niculescu-Duvaz, Dan ;
Zambon, Alfonso ;
Sinclair, John ;
Hayes, Andrew ;
Gore, Martin ;
Lorigan, Paul ;
Springer, Caroline ;
Larkin, James ;
Jorgensen, Claus ;
Marais, Richard .
CANCER DISCOVERY, 2013, 3 (02) :158-167
[5]   Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model [J].
Lee, Samantha Lin Chiou ;
Rouhi, Pegah ;
Jensen, Lasse Dahl ;
Zhang, Danfang ;
Ji, Hong ;
Hauptmann, Giselbert ;
Ingham, Philip ;
Cao, Yihai .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (46) :19485-19490
[6]   Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma [J].
Menzies, Alexander M. ;
Haydu, Lauren E. ;
Carlino, Matteo S. ;
Azer, Mary W. F. ;
Carr, Peter J. A. ;
Kefford, Richard F. ;
Long, Georgina V. .
PLOS ONE, 2014, 9 (01)
[7]   EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt [J].
Miao, Hui ;
Li, Da-Qiang ;
Mukherjee, Amitava ;
Guo, Hong ;
Petty, Aaron ;
Cutter, Jennifer ;
Basilion, James P. ;
Sedor, John ;
Wu, Jiong ;
Danielpour, David ;
Sloan, Andrew E. ;
Cohen, Mark L. ;
Wang, Bingcheng .
CANCER CELL, 2009, 16 (01) :9-20
[8]   Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy-Mediated Metastatic Melanoma Phenotype [J].
Paraiso, Kim H. T. ;
Das Thakur, Meghna ;
Fang, Bin ;
Koomen, John M. ;
Fedorenko, Inna V. ;
John, Jobin K. ;
Tsao, Hensin ;
Flaherty, Keith T. ;
Sondak, Vernon K. ;
Messina, Jane L. ;
Pasquale, Elena B. ;
Villagra, Alejandro ;
Rao, Uma N. ;
Kirkwood, John M. ;
Meier, Friedegund ;
Sloot, Sarah ;
Gibney, Geoffrey T. ;
Stuart, Darrin ;
Tawbi, Hussein ;
Smalley, Keiran S. M. .
CANCER DISCOVERY, 2015, 5 (03) :264-273
[9]   Eph receptors and ephrins in cancer: bidirectional signalling and beyond [J].
Pasquale, Elena B. .
NATURE REVIEWS CANCER, 2010, 10 (03) :165-180
[10]   BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma [J].
Shao, Y. ;
Aplin, A. E. .
CELL DEATH AND DIFFERENTIATION, 2012, 19 (12) :2029-2039